世界のダウノルビシン市場予測（～2028年）：静脈、点滴

• 英文タイトル：Global Daunorubicin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E8782 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

ダウノルビシン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のダウノルビシンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 ダウノルビシン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・静脈、点滴 用途別セグメントは次のように区分されます。 ・急性顆粒球、急性リンパ球白血病 世界のダウノルビシン市場の主要な市場プレーヤーは以下のとおりです。 ・Sanofi、Halison Pharmaceuiticals、Hikma Pharmaceuticals、Gilead Sciences、Bedford Pharmaceuticals、United Biotech、Mercian Corporation、Pharmacia、Cipla、TEVA、Medior Healthcare、West-Ward、Shandong Xinshidai Pharmaceutical、HISUN、Shenzhen Wanle Pharmaceutical 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、ダウノルビシン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なダウノルビシンメーカーの企業概要、2019年～2022年までのダウノルビシンの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なダウノルビシンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別ダウノルビシンの販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までのダウノルビシンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのダウノルビシン市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、およびダウノルビシンの産業チェーンを掲載しています。 ・第13、14、15章では、ダウノルビシンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Sanofi、Halison Pharmaceuiticals、Hikma Pharmaceuticals、Gilead Sciences、Bedford Pharmaceuticals、United Biotech、Mercian Corporation、Pharmacia、Cipla、TEVA、Medior Healthcare、West-Ward、Shandong Xinshidai Pharmaceutical、HISUN、Shenzhen Wanle Pharmaceutical ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：静脈、点滴 ・用途別分析2017年-2028年：急性顆粒球、急性リンパ球白血病 ・ダウノルビシンの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・ダウノルビシンのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・ダウノルビシンのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ダウノルビシンの南米市場規模2017年-2028年：ブラジル、アルゼンチン ・ダウノルビシンの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Daunorubicin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Daunorubicin market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Acute Granulocyte accounting for % of the Daunorubicin global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Intravenous segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Daunorubicin include Sanofi, Halison Pharmaceuiticals, Hikma Pharmaceuticals, Gilead Sciences, and Bedford Pharmaceuticals, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Daunorubicin market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Intravenous
Drip
Market segment by Application can be divided into
Acute Granulocyte
Acute Lymphocyte Leukemia
The key market players for global Daunorubicin market are listed below:
Sanofi
Halison Pharmaceuiticals
Hikma Pharmaceuticals
Gilead Sciences
Bedford Pharmaceuticals
United Biotech
Mercian Corporation
Pharmacia
Cipla
TEVA
Medior Healthcare
West-Ward
Shandong Xinshidai Pharmaceutical
HISUN
Shenzhen Wanle Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Daunorubicin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Daunorubicin, with price, sales, revenue and global market share of Daunorubicin from 2019 to 2022.
Chapter 3, the Daunorubicin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Daunorubicin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Daunorubicin market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Daunorubicin.
Chapter 13, 14, and 15, to describe Daunorubicin sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Daunorubicin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Daunorubicin Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Intravenous
1.2.3 Drip
1.3 Market Analysis by Application
1.3.1 Overview: Global Daunorubicin Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Acute Granulocyte
1.3.3 Acute Lymphocyte Leukemia
1.4 Global Daunorubicin Market Size & Forecast
1.4.1 Global Daunorubicin Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Daunorubicin Sales in Volume (2017-2028)
1.4.3 Global Daunorubicin Price (2017-2028)
1.5 Global Daunorubicin Production Capacity Analysis
1.5.1 Global Daunorubicin Total Production Capacity (2017-2028)
1.5.2 Global Daunorubicin Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Daunorubicin Market Drivers
1.6.2 Daunorubicin Market Restraints
1.6.3 Daunorubicin Trends Analysis
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Daunorubicin Product and Services
2.1.4 Sanofi Daunorubicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Halison Pharmaceuiticals
2.2.1 Halison Pharmaceuiticals Details
2.2.2 Halison Pharmaceuiticals Major Business
2.2.3 Halison Pharmaceuiticals Daunorubicin Product and Services
2.2.4 Halison Pharmaceuiticals Daunorubicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Hikma Pharmaceuticals
2.3.1 Hikma Pharmaceuticals Details
2.3.2 Hikma Pharmaceuticals Major Business
2.3.3 Hikma Pharmaceuticals Daunorubicin Product and Services
2.3.4 Hikma Pharmaceuticals Daunorubicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Gilead Sciences
2.4.1 Gilead Sciences Details
2.4.2 Gilead Sciences Major Business
2.4.3 Gilead Sciences Daunorubicin Product and Services
2.4.4 Gilead Sciences Daunorubicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Bedford Pharmaceuticals
2.5.1 Bedford Pharmaceuticals Details
2.5.2 Bedford Pharmaceuticals Major Business
2.5.3 Bedford Pharmaceuticals Daunorubicin Product and Services
2.5.4 Bedford Pharmaceuticals Daunorubicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 United Biotech
2.6.1 United Biotech Details
2.6.2 United Biotech Major Business
2.6.3 United Biotech Daunorubicin Product and Services
2.6.4 United Biotech Daunorubicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Mercian Corporation
2.7.1 Mercian Corporation Details
2.7.2 Mercian Corporation Major Business
2.7.3 Mercian Corporation Daunorubicin Product and Services
2.7.4 Mercian Corporation Daunorubicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Pharmacia
2.8.1 Pharmacia Details
2.8.2 Pharmacia Major Business
2.8.3 Pharmacia Daunorubicin Product and Services
2.8.4 Pharmacia Daunorubicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Cipla
2.9.1 Cipla Details
2.9.2 Cipla Major Business
2.9.3 Cipla Daunorubicin Product and Services
2.9.4 Cipla Daunorubicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 TEVA
2.10.1 TEVA Details
2.10.2 TEVA Major Business
2.10.3 TEVA Daunorubicin Product and Services
2.10.4 TEVA Daunorubicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Medior Healthcare
2.11.1 Medior Healthcare Details
2.11.2 Medior Healthcare Major Business
2.11.3 Medior Healthcare Daunorubicin Product and Services
2.11.4 Medior Healthcare Daunorubicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 West-Ward
2.12.1 West-Ward Details
2.12.2 West-Ward Major Business
2.12.3 West-Ward Daunorubicin Product and Services
2.12.4 West-Ward Daunorubicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Shandong Xinshidai Pharmaceutical
2.13.1 Shandong Xinshidai Pharmaceutical Details
2.13.2 Shandong Xinshidai Pharmaceutical Major Business
2.13.3 Shandong Xinshidai Pharmaceutical Daunorubicin Product and Services
2.13.4 Shandong Xinshidai Pharmaceutical Daunorubicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 HISUN
2.14.1 HISUN Details
2.14.2 HISUN Major Business
2.14.3 HISUN Daunorubicin Product and Services
2.14.4 HISUN Daunorubicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Shenzhen Wanle Pharmaceutical
2.15.1 Shenzhen Wanle Pharmaceutical Details
2.15.2 Shenzhen Wanle Pharmaceutical Major Business
2.15.3 Shenzhen Wanle Pharmaceutical Daunorubicin Product and Services
2.15.4 Shenzhen Wanle Pharmaceutical Daunorubicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Daunorubicin Breakdown Data by Manufacturer
3.1 Global Daunorubicin Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Daunorubicin Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Daunorubicin
3.4 Market Concentration Rate
3.4.1 Top 3 Daunorubicin Manufacturer Market Share in 2021
3.4.2 Top 6 Daunorubicin Manufacturer Market Share in 2021
3.5 Global Daunorubicin Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Daunorubicin Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Daunorubicin Market Size by Region
4.1.1 Global Daunorubicin Sales in Volume by Region (2017-2028)
4.1.2 Global Daunorubicin Revenue by Region (2017-2028)
4.2 North America Daunorubicin Revenue (2017-2028)
4.3 Europe Daunorubicin Revenue (2017-2028)
4.4 Asia-Pacific Daunorubicin Revenue (2017-2028)
4.5 South America Daunorubicin Revenue (2017-2028)
4.6 Middle East and Africa Daunorubicin Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Daunorubicin Sales in Volume by Type (2017-2028)
5.2 Global Daunorubicin Revenue by Type (2017-2028)
5.3 Global Daunorubicin Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Daunorubicin Sales in Volume by Application (2017-2028)
6.2 Global Daunorubicin Revenue by Application (2017-2028)
6.3 Global Daunorubicin Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Daunorubicin Sales by Type (2017-2028)
7.2 North America Daunorubicin Sales by Application (2017-2028)
7.3 North America Daunorubicin Market Size by Country
7.3.1 North America Daunorubicin Sales in Volume by Country (2017-2028)
7.3.2 North America Daunorubicin Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Daunorubicin Sales by Type (2017-2028)
8.2 Europe Daunorubicin Sales by Application (2017-2028)
8.3 Europe Daunorubicin Market Size by Country
8.3.1 Europe Daunorubicin Sales in Volume by Country (2017-2028)
8.3.2 Europe Daunorubicin Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Daunorubicin Sales by Type (2017-2028)
9.2 Asia-Pacific Daunorubicin Sales by Application (2017-2028)
9.3 Asia-Pacific Daunorubicin Market Size by Region
9.3.1 Asia-Pacific Daunorubicin Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Daunorubicin Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Daunorubicin Sales by Type (2017-2028)
10.2 South America Daunorubicin Sales by Application (2017-2028)
10.3 South America Daunorubicin Market Size by Country
10.3.1 South America Daunorubicin Sales in Volume by Country (2017-2028)
10.3.2 South America Daunorubicin Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Daunorubicin Sales by Type (2017-2028)
11.2 Middle East & Africa Daunorubicin Sales by Application (2017-2028)
11.3 Middle East & Africa Daunorubicin Market Size by Country
11.3.1 Middle East & Africa Daunorubicin Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Daunorubicin Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Daunorubicin and Key Manufacturers
12.2 Manufacturing Costs Percentage of Daunorubicin
12.3 Daunorubicin Production Process
12.4 Daunorubicin Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Daunorubicin Typical Distributors
13.3 Daunorubicin Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---